nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—ITGAL—endothelium—malignant glioma	0.0244	0.13	CbGeAlD
Lovastatin—ITGAL—blood vessel—malignant glioma	0.0225	0.12	CbGeAlD
Lovastatin—HDAC2—telencephalic ventricle—malignant glioma	0.0182	0.0968	CbGeAlD
Lovastatin—VIIth nerve paralysis—Carmustine—malignant glioma	0.0114	0.0516	CcSEcCtD
Lovastatin—Simvastatin—CYP2B6—malignant glioma	0.00943	1	CrCbGaD
Lovastatin—ITGAL—medulla oblongata—malignant glioma	0.00858	0.0457	CbGeAlD
Lovastatin—ITGAL—midbrain—malignant glioma	0.00784	0.0418	CbGeAlD
Lovastatin—Transaminases increased—Carmustine—malignant glioma	0.00767	0.0348	CcSEcCtD
Lovastatin—ITGAL—spinal cord—malignant glioma	0.00765	0.0407	CbGeAlD
Lovastatin—Myopathy—Temozolomide—malignant glioma	0.00643	0.0292	CcSEcCtD
Lovastatin—ITGAL—cerebellum—malignant glioma	0.00607	0.0323	CbGeAlD
Lovastatin—Memory impairment—Temozolomide—malignant glioma	0.00574	0.0261	CcSEcCtD
Lovastatin—HDAC2—embryo—malignant glioma	0.00537	0.0286	CbGeAlD
Lovastatin—Accidental injury—Carmustine—malignant glioma	0.00527	0.0239	CcSEcCtD
Lovastatin—ITGAL—brain—malignant glioma	0.00493	0.0262	CbGeAlD
Lovastatin—HDAC2—brainstem—malignant glioma	0.00492	0.0262	CbGeAlD
Lovastatin—PON3—brain—malignant glioma	0.00483	0.0257	CbGeAlD
Lovastatin—HDAC2—retina—malignant glioma	0.00475	0.0253	CbGeAlD
Lovastatin—Musculoskeletal pain—Temozolomide—malignant glioma	0.00456	0.0207	CcSEcCtD
Lovastatin—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00451	0.0205	CcSEcCtD
Lovastatin—HDAC2—telencephalon—malignant glioma	0.00437	0.0232	CbGeAlD
Lovastatin—Gynaecomastia—Carmustine—malignant glioma	0.00417	0.019	CcSEcCtD
Lovastatin—HMGCR—telencephalon—malignant glioma	0.00394	0.021	CbGeAlD
Lovastatin—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00376	0.0171	CcSEcCtD
Lovastatin—Injury—Carmustine—malignant glioma	0.00368	0.0167	CcSEcCtD
Lovastatin—Vascular purpura—Temozolomide—malignant glioma	0.00366	0.0166	CcSEcCtD
Lovastatin—Hepatic failure—Temozolomide—malignant glioma	0.00364	0.0165	CcSEcCtD
Lovastatin—Amnesia—Carmustine—malignant glioma	0.0036	0.0164	CcSEcCtD
Lovastatin—Amnesia—Temozolomide—malignant glioma	0.00348	0.0158	CcSEcCtD
Lovastatin—HDAC2—medulla oblongata—malignant glioma	0.00343	0.0183	CbGeAlD
Lovastatin—Purpura—Temozolomide—malignant glioma	0.0034	0.0154	CcSEcCtD
Lovastatin—HDAC2—midbrain—malignant glioma	0.00314	0.0167	CbGeAlD
Lovastatin—HMGCR—medulla oblongata—malignant glioma	0.0031	0.0165	CbGeAlD
Lovastatin—SLCO1A2—telencephalon—malignant glioma	0.00307	0.0163	CbGeAlD
Lovastatin—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00295	0.0134	CcSEcCtD
Lovastatin—HMGCR—midbrain—malignant glioma	0.00283	0.0151	CbGeAlD
Lovastatin—HMGCR—spinal cord—malignant glioma	0.00276	0.0147	CbGeAlD
Lovastatin—Erectile dysfunction—Temozolomide—malignant glioma	0.00261	0.0118	CcSEcCtD
Lovastatin—Photosensitivity reaction—Temozolomide—malignant glioma	0.00258	0.0117	CcSEcCtD
Lovastatin—Neuropathy peripheral—Carmustine—malignant glioma	0.00256	0.0116	CcSEcCtD
Lovastatin—Urinary tract infection—Carmustine—malignant glioma	0.00254	0.0115	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.0025	0.0114	CcSEcCtD
Lovastatin—HDAC2—central nervous system—malignant glioma	0.00248	0.0132	CbGeAlD
Lovastatin—Neuropathy peripheral—Temozolomide—malignant glioma	0.00247	0.0112	CcSEcCtD
Lovastatin—Urinary tract infection—Temozolomide—malignant glioma	0.00245	0.0111	CcSEcCtD
Lovastatin—HDAC2—cerebellum—malignant glioma	0.00243	0.0129	CbGeAlD
Lovastatin—SLCO1A2—medulla oblongata—malignant glioma	0.00241	0.0128	CbGeAlD
Lovastatin—Sinusitis—Temozolomide—malignant glioma	0.00237	0.0107	CcSEcCtD
Lovastatin—Hepatitis—Temozolomide—malignant glioma	0.00226	0.0103	CcSEcCtD
Lovastatin—HMGCR—central nervous system—malignant glioma	0.00224	0.0119	CbGeAlD
Lovastatin—SLCO1A2—midbrain—malignant glioma	0.00221	0.0117	CbGeAlD
Lovastatin—HMGCR—cerebellum—malignant glioma	0.00219	0.0117	CbGeAlD
Lovastatin—Flushing—Carmustine—malignant glioma	0.00217	0.00987	CcSEcCtD
Lovastatin—SLCO1A2—spinal cord—malignant glioma	0.00215	0.0115	CbGeAlD
Lovastatin—Erythema multiforme—Temozolomide—malignant glioma	0.00214	0.00972	CcSEcCtD
Lovastatin—ABCB1—blood vessel—malignant glioma	0.00212	0.0113	CbGeAlD
Lovastatin—Flushing—Temozolomide—malignant glioma	0.0021	0.00954	CcSEcCtD
Lovastatin—Alopecia—Carmustine—malignant glioma	0.00207	0.0094	CcSEcCtD
Lovastatin—Chills—Temozolomide—malignant glioma	0.00203	0.00922	CcSEcCtD
Lovastatin—Alopecia—Temozolomide—malignant glioma	0.002	0.00908	CcSEcCtD
Lovastatin—Back pain—Carmustine—malignant glioma	0.00197	0.00896	CcSEcCtD
Lovastatin—HDAC2—brain—malignant glioma	0.00197	0.0105	CbGeAlD
Lovastatin—Dysgeusia—Temozolomide—malignant glioma	0.00193	0.00876	CcSEcCtD
Lovastatin—Vision blurred—Carmustine—malignant glioma	0.00192	0.00873	CcSEcCtD
Lovastatin—Tremor—Carmustine—malignant glioma	0.00191	0.00868	CcSEcCtD
Lovastatin—Back pain—Temozolomide—malignant glioma	0.00191	0.00866	CcSEcCtD
Lovastatin—Vision blurred—Temozolomide—malignant glioma	0.00186	0.00843	CcSEcCtD
Lovastatin—Tremor—Temozolomide—malignant glioma	0.00185	0.00838	CcSEcCtD
Lovastatin—Ill-defined disorder—Temozolomide—malignant glioma	0.00183	0.0083	CcSEcCtD
Lovastatin—Leukopenia—Carmustine—malignant glioma	0.00183	0.00829	CcSEcCtD
Lovastatin—Angioedema—Temozolomide—malignant glioma	0.0018	0.00818	CcSEcCtD
Lovastatin—HMGCR—brain—malignant glioma	0.00178	0.00946	CbGeAlD
Lovastatin—Malaise—Temozolomide—malignant glioma	0.00178	0.00807	CcSEcCtD
Lovastatin—Vertigo—Temozolomide—malignant glioma	0.00177	0.00804	CcSEcCtD
Lovastatin—Leukopenia—Temozolomide—malignant glioma	0.00176	0.00801	CcSEcCtD
Lovastatin—SLCO1A2—central nervous system—malignant glioma	0.00175	0.00929	CbGeAlD
Lovastatin—Chest pain—Carmustine—malignant glioma	0.00174	0.00788	CcSEcCtD
Lovastatin—Myalgia—Carmustine—malignant glioma	0.00174	0.00788	CcSEcCtD
Lovastatin—Anxiety—Carmustine—malignant glioma	0.00173	0.00786	CcSEcCtD
Lovastatin—SLCO1A2—cerebellum—malignant glioma	0.00171	0.00908	CbGeAlD
Lovastatin—Confusional state—Carmustine—malignant glioma	0.00168	0.00762	CcSEcCtD
Lovastatin—Arthralgia—Temozolomide—malignant glioma	0.00168	0.00762	CcSEcCtD
Lovastatin—Myalgia—Temozolomide—malignant glioma	0.00168	0.00762	CcSEcCtD
Lovastatin—Anxiety—Temozolomide—malignant glioma	0.00167	0.00759	CcSEcCtD
Lovastatin—Discomfort—Temozolomide—malignant glioma	0.00166	0.00753	CcSEcCtD
Lovastatin—Infection—Carmustine—malignant glioma	0.00165	0.00751	CcSEcCtD
Lovastatin—Dry mouth—Temozolomide—malignant glioma	0.00164	0.00745	CcSEcCtD
Lovastatin—Thrombocytopenia—Carmustine—malignant glioma	0.00163	0.0074	CcSEcCtD
Lovastatin—Confusional state—Temozolomide—malignant glioma	0.00162	0.00736	CcSEcCtD
Lovastatin—CYP2D6—brainstem—malignant glioma	0.00161	0.00858	CbGeAlD
Lovastatin—Anaphylactic shock—Temozolomide—malignant glioma	0.00161	0.0073	CcSEcCtD
Lovastatin—Infection—Temozolomide—malignant glioma	0.0016	0.00726	CcSEcCtD
Lovastatin—Anorexia—Carmustine—malignant glioma	0.00159	0.0072	CcSEcCtD
Lovastatin—Thrombocytopenia—Temozolomide—malignant glioma	0.00158	0.00715	CcSEcCtD
Lovastatin—Anorexia—Temozolomide—malignant glioma	0.00153	0.00696	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00152	0.00688	CcSEcCtD
Lovastatin—Insomnia—Carmustine—malignant glioma	0.00151	0.00683	CcSEcCtD
Lovastatin—Paraesthesia—Carmustine—malignant glioma	0.00149	0.00679	CcSEcCtD
Lovastatin—Dyspnoea—Carmustine—malignant glioma	0.00148	0.00674	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00147	0.00665	CcSEcCtD
Lovastatin—Insomnia—Temozolomide—malignant glioma	0.00145	0.00661	CcSEcCtD
Lovastatin—Decreased appetite—Carmustine—malignant glioma	0.00145	0.00657	CcSEcCtD
Lovastatin—Paraesthesia—Temozolomide—malignant glioma	0.00144	0.00656	CcSEcCtD
Lovastatin—Dyspnoea—Temozolomide—malignant glioma	0.00143	0.00651	CcSEcCtD
Lovastatin—CYP2D6—telencephalon—malignant glioma	0.00143	0.00761	CbGeAlD
Lovastatin—Constipation—Carmustine—malignant glioma	0.00142	0.00646	CcSEcCtD
Lovastatin—Pain—Carmustine—malignant glioma	0.00142	0.00646	CcSEcCtD
Lovastatin—Dyspepsia—Temozolomide—malignant glioma	0.00142	0.00643	CcSEcCtD
Lovastatin—Decreased appetite—Temozolomide—malignant glioma	0.0014	0.00635	CcSEcCtD
Lovastatin—Fatigue—Temozolomide—malignant glioma	0.00139	0.0063	CcSEcCtD
Lovastatin—SLCO1A2—brain—malignant glioma	0.00139	0.00738	CbGeAlD
Lovastatin—Constipation—Temozolomide—malignant glioma	0.00138	0.00624	CcSEcCtD
Lovastatin—Pain—Temozolomide—malignant glioma	0.00138	0.00624	CcSEcCtD
Lovastatin—Feeling abnormal—Carmustine—malignant glioma	0.00137	0.00623	CcSEcCtD
Lovastatin—Gastrointestinal pain—Carmustine—malignant glioma	0.00136	0.00618	CcSEcCtD
Lovastatin—Feeling abnormal—Temozolomide—malignant glioma	0.00133	0.00602	CcSEcCtD
Lovastatin—Body temperature increased—Carmustine—malignant glioma	0.00132	0.00597	CcSEcCtD
Lovastatin—Abdominal pain—Carmustine—malignant glioma	0.00132	0.00597	CcSEcCtD
Lovastatin—Gastrointestinal pain—Temozolomide—malignant glioma	0.00132	0.00597	CcSEcCtD
Lovastatin—Urticaria—Temozolomide—malignant glioma	0.00128	0.0058	CcSEcCtD
Lovastatin—Abdominal pain—Temozolomide—malignant glioma	0.00127	0.00577	CcSEcCtD
Lovastatin—Body temperature increased—Temozolomide—malignant glioma	0.00127	0.00577	CcSEcCtD
Lovastatin—ABCB1—embryo—malignant glioma	0.00127	0.00673	CbGeAlD
Lovastatin—Hypersensitivity—Carmustine—malignant glioma	0.00123	0.00557	CcSEcCtD
Lovastatin—Asthenia—Carmustine—malignant glioma	0.00119	0.00542	CcSEcCtD
Lovastatin—Hypersensitivity—Temozolomide—malignant glioma	0.00119	0.00538	CcSEcCtD
Lovastatin—Asthenia—Temozolomide—malignant glioma	0.00115	0.00524	CcSEcCtD
Lovastatin—Diarrhoea—Carmustine—malignant glioma	0.00114	0.00517	CcSEcCtD
Lovastatin—Pruritus—Temozolomide—malignant glioma	0.00114	0.00517	CcSEcCtD
Lovastatin—ABCB1—retina—malignant glioma	0.00112	0.00595	CbGeAlD
Lovastatin—Dizziness—Carmustine—malignant glioma	0.0011	0.005	CcSEcCtD
Lovastatin—Diarrhoea—Temozolomide—malignant glioma	0.0011	0.005	CcSEcCtD
Lovastatin—Dizziness—Temozolomide—malignant glioma	0.00106	0.00483	CcSEcCtD
Lovastatin—Vomiting—Carmustine—malignant glioma	0.00106	0.0048	CcSEcCtD
Lovastatin—Rash—Carmustine—malignant glioma	0.00105	0.00476	CcSEcCtD
Lovastatin—Dermatitis—Carmustine—malignant glioma	0.00105	0.00476	CcSEcCtD
Lovastatin—Headache—Carmustine—malignant glioma	0.00104	0.00473	CcSEcCtD
Lovastatin—ABCB1—telencephalon—malignant glioma	0.00103	0.00548	CbGeAlD
Lovastatin—Vomiting—Temozolomide—malignant glioma	0.00102	0.00464	CcSEcCtD
Lovastatin—Rash—Temozolomide—malignant glioma	0.00101	0.0046	CcSEcCtD
Lovastatin—Dermatitis—Temozolomide—malignant glioma	0.00101	0.0046	CcSEcCtD
Lovastatin—Headache—Temozolomide—malignant glioma	0.00101	0.00457	CcSEcCtD
Lovastatin—Nausea—Carmustine—malignant glioma	0.000989	0.00449	CcSEcCtD
Lovastatin—CYP2C8—brain—malignant glioma	0.000968	0.00515	CbGeAlD
Lovastatin—Nausea—Temozolomide—malignant glioma	0.000956	0.00434	CcSEcCtD
Lovastatin—CYP3A4—central nervous system—malignant glioma	0.000826	0.0044	CbGeAlD
Lovastatin—CYP2D6—central nervous system—malignant glioma	0.000813	0.00433	CbGeAlD
Lovastatin—ABCB1—medulla oblongata—malignant glioma	0.000808	0.0043	CbGeAlD
Lovastatin—CYP2D6—cerebellum—malignant glioma	0.000795	0.00423	CbGeAlD
Lovastatin—ABCB1—midbrain—malignant glioma	0.000739	0.00393	CbGeAlD
Lovastatin—ABCB1—spinal cord—malignant glioma	0.000721	0.00384	CbGeAlD
Lovastatin—CYP2D6—brain—malignant glioma	0.000645	0.00344	CbGeAlD
Lovastatin—ABCB1—central nervous system—malignant glioma	0.000585	0.00311	CbGeAlD
Lovastatin—ABCB1—cerebellum—malignant glioma	0.000572	0.00304	CbGeAlD
Lovastatin—ABCB1—brain—malignant glioma	0.000464	0.00247	CbGeAlD
Lovastatin—HDAC2—Signaling Pathways—F2—malignant glioma	4.2e-05	7.21e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—NCOR1—malignant glioma	4.18e-05	7.18e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GSTP1—malignant glioma	4.18e-05	7.17e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CG—malignant glioma	4.17e-05	7.16e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP2C18—malignant glioma	4.16e-05	7.15e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—BAD—malignant glioma	4.15e-05	7.13e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SPHK1—malignant glioma	4.15e-05	7.12e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NOTCH1—malignant glioma	4.11e-05	7.06e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGS1—malignant glioma	4.08e-05	7.01e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CAT—malignant glioma	4.06e-05	6.98e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP2C18—malignant glioma	4.06e-05	6.98e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ASMT—malignant glioma	4.05e-05	6.96e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—IDH1—malignant glioma	4.04e-05	6.94e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CD80—malignant glioma	4.03e-05	6.92e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PPARG—malignant glioma	4.02e-05	6.91e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CG—malignant glioma	4.02e-05	6.9e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—APC—malignant glioma	4.02e-05	6.9e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.01e-05	6.88e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—IDH1—malignant glioma	4e-05	6.88e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CAV1—malignant glioma	3.99e-05	6.84e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PTEN—malignant glioma	3.98e-05	6.84e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EGF—malignant glioma	3.98e-05	6.83e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PTPN11—malignant glioma	3.95e-05	6.78e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.93e-05	6.74e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SPHK1—malignant glioma	3.91e-05	6.71e-05	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	3.9e-05	6.7e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SPHK1—malignant glioma	3.88e-05	6.65e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.87e-05	6.64e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—NCOR1—malignant glioma	3.84e-05	6.59e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP2C18—malignant glioma	3.83e-05	6.57e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—BCAN—malignant glioma	3.81e-05	6.54e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.81e-05	6.54e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PTEN—malignant glioma	3.8e-05	6.53e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP2C18—malignant glioma	3.8e-05	6.52e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—BCHE—malignant glioma	3.79e-05	6.51e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—BRAF—malignant glioma	3.78e-05	6.49e-05	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	3.78e-05	6.49e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTT1—malignant glioma	3.77e-05	6.48e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PIK3CB—malignant glioma	3.76e-05	6.45e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—SLC5A5—malignant glioma	3.75e-05	6.43e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTGS2—malignant glioma	3.72e-05	6.39e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CAV1—malignant glioma	3.72e-05	6.39e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AKT2—malignant glioma	3.68e-05	6.32e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CD—malignant glioma	3.67e-05	6.29e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CG—malignant glioma	3.63e-05	6.23e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.58e-05	6.15e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.58e-05	6.14e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CD—malignant glioma	3.54e-05	6.07e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGS1—malignant glioma	3.54e-05	6.07e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.52e-05	6.05e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PPARG—malignant glioma	3.5e-05	6.02e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.45e-05	5.93e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CAV1—malignant glioma	3.41e-05	5.85e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MYC—malignant glioma	3.4e-05	5.84e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—STAT3—malignant glioma	3.4e-05	5.84e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CG—malignant glioma	3.39e-05	5.82e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGF2—malignant glioma	3.38e-05	5.81e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTT1—malignant glioma	3.37e-05	5.78e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTT1—malignant glioma	3.29e-05	5.64e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—BCHE—malignant glioma	3.29e-05	5.64e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PPARG—malignant glioma	3.27e-05	5.62e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.26e-05	5.6e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.26e-05	5.59e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTEN—malignant glioma	3.25e-05	5.58e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SLC5A5—malignant glioma	3.25e-05	5.57e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CB—malignant glioma	3.2e-05	5.49e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CD—malignant glioma	3.19e-05	5.48e-05	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	3.19e-05	5.48e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MDM2—malignant glioma	3.17e-05	5.44e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTGS2—malignant glioma	3.17e-05	5.44e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MYC—malignant glioma	3.16e-05	5.43e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RAF1—malignant glioma	3.16e-05	5.42e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGS1—malignant glioma	3.16e-05	5.42e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.15e-05	5.4e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.14e-05	5.4e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CAV1—malignant glioma	3.13e-05	5.37e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ERBB2—malignant glioma	3.12e-05	5.36e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CG—malignant glioma	3.11e-05	5.33e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTT1—malignant glioma	3.1e-05	5.32e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—EGFR—malignant glioma	3.09e-05	5.31e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CB—malignant glioma	3.08e-05	5.29e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGS1—malignant glioma	3.08e-05	5.29e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—IDH2—malignant glioma	3.07e-05	5.27e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTT1—malignant glioma	3.07e-05	5.27e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.07e-05	5.27e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.04e-05	5.22e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GSTP1—malignant glioma	3.02e-05	5.18e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PPARG—malignant glioma	3e-05	5.15e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CD—malignant glioma	2.98e-05	5.11e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCL8—malignant glioma	2.96e-05	5.08e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CAT—malignant glioma	2.94e-05	5.04e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—BCHE—malignant glioma	2.93e-05	5.04e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—KRAS—malignant glioma	2.92e-05	5.01e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGS1—malignant glioma	2.9e-05	4.98e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SLC5A5—malignant glioma	2.9e-05	4.97e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.89e-05	4.96e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGS1—malignant glioma	2.88e-05	4.94e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.87e-05	4.92e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—BCHE—malignant glioma	2.86e-05	4.92e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CG—malignant glioma	2.85e-05	4.89e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CASP3—malignant glioma	2.83e-05	4.87e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL2—malignant glioma	2.83e-05	4.86e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SLC5A5—malignant glioma	2.83e-05	4.86e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PIK3CA—malignant glioma	2.81e-05	4.82e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CB—malignant glioma	2.78e-05	4.78e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—NCOR1—malignant glioma	2.77e-05	4.76e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTEN—malignant glioma	2.76e-05	4.74e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTGS2—malignant glioma	2.76e-05	4.73e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PPARG—malignant glioma	2.75e-05	4.72e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.74e-05	4.7e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CD—malignant glioma	2.73e-05	4.69e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.72e-05	4.66e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—BCHE—malignant glioma	2.7e-05	4.63e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PIK3CA—malignant glioma	2.68e-05	4.61e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MMP9—malignant glioma	2.68e-05	4.6e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—BCHE—malignant glioma	2.67e-05	4.59e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SLC5A5—malignant glioma	2.67e-05	4.58e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PTEN—malignant glioma	2.66e-05	4.57e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.65e-05	4.55e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SLC5A5—malignant glioma	2.64e-05	4.54e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—IDH1—malignant glioma	2.64e-05	4.53e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTP1—malignant glioma	2.61e-05	4.49e-05	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.6e-05	4.47e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CB—malignant glioma	2.6e-05	4.46e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTGS2—malignant glioma	2.57e-05	4.42e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SPHK1—malignant glioma	2.56e-05	4.39e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CAT—malignant glioma	2.54e-05	4.37e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CD—malignant glioma	2.51e-05	4.3e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.5e-05	4.3e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.5e-05	4.29e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.48e-05	4.25e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VEGFA—malignant glioma	2.41e-05	4.13e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTEN—malignant glioma	2.4e-05	4.13e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—NCOR1—malignant glioma	2.4e-05	4.13e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—STAT3—malignant glioma	2.38e-05	4.09e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CB—malignant glioma	2.38e-05	4.09e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.37e-05	4.07e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—AKT1—malignant glioma	2.36e-05	4.05e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTGS2—malignant glioma	2.36e-05	4.05e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTP1—malignant glioma	2.33e-05	4.01e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AKT1—malignant glioma	2.3e-05	3.94e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PIK3CA—malignant glioma	2.29e-05	3.93e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTP1—malignant glioma	2.28e-05	3.91e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CAT—malignant glioma	2.27e-05	3.9e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CAV1—malignant glioma	2.26e-05	3.88e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTEN—malignant glioma	2.24e-05	3.85e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CAT—malignant glioma	2.22e-05	3.81e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MYC—malignant glioma	2.21e-05	3.8e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—AKT1—malignant glioma	2.19e-05	3.76e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CB—malignant glioma	2.18e-05	3.75e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EGFR—malignant glioma	2.16e-05	3.72e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTGS2—malignant glioma	2.16e-05	3.71e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.16e-05	3.71e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTP1—malignant glioma	2.15e-05	3.69e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—NCOR1—malignant glioma	2.14e-05	3.68e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTP1—malignant glioma	2.13e-05	3.65e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—NCOR1—malignant glioma	2.09e-05	3.59e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CAT—malignant glioma	2.09e-05	3.59e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CAT—malignant glioma	2.07e-05	3.56e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CG—malignant glioma	2.06e-05	3.54e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTEN—malignant glioma	2.06e-05	3.53e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KRAS—malignant glioma	2.04e-05	3.51e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTT1—malignant glioma	2.02e-05	3.48e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PPARG—malignant glioma	1.99e-05	3.41e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NCOR1—malignant glioma	1.97e-05	3.39e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CAV1—malignant glioma	1.96e-05	3.36e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NCOR1—malignant glioma	1.96e-05	3.36e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CA—malignant glioma	1.95e-05	3.34e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS1—malignant glioma	1.9e-05	3.26e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTEN—malignant glioma	1.89e-05	3.24e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CA—malignant glioma	1.88e-05	3.23e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.87e-05	3.21e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AKT1—malignant glioma	1.87e-05	3.21e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TP53—malignant glioma	1.82e-05	3.12e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CD—malignant glioma	1.81e-05	3.11e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CG—malignant glioma	1.78e-05	3.06e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—BCHE—malignant glioma	1.76e-05	3.03e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CAV1—malignant glioma	1.75e-05	3e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.74e-05	2.99e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PPARG—malignant glioma	1.72e-05	2.96e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CAV1—malignant glioma	1.71e-05	2.93e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CA—malignant glioma	1.7e-05	2.91e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.67e-05	2.87e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CAV1—malignant glioma	1.61e-05	2.76e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CAV1—malignant glioma	1.59e-05	2.74e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CG—malignant glioma	1.59e-05	2.73e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AKT1—malignant glioma	1.59e-05	2.73e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CA—malignant glioma	1.58e-05	2.72e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.58e-05	2.71e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CD—malignant glioma	1.57e-05	2.69e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGS2—malignant glioma	1.56e-05	2.69e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CG—malignant glioma	1.55e-05	2.67e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PPARG—malignant glioma	1.54e-05	2.64e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AKT1—malignant glioma	1.53e-05	2.63e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.52e-05	2.62e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PPARG—malignant glioma	1.5e-05	2.58e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.46e-05	2.52e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.45e-05	2.49e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CA—malignant glioma	1.45e-05	2.49e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PPARG—malignant glioma	1.41e-05	2.43e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTP1—malignant glioma	1.4e-05	2.41e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PPARG—malignant glioma	1.4e-05	2.41e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.4e-05	2.4e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AKT1—malignant glioma	1.39e-05	2.38e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CB—malignant glioma	1.37e-05	2.35e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CD—malignant glioma	1.37e-05	2.35e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CAT—malignant glioma	1.37e-05	2.34e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTEN—malignant glioma	1.36e-05	2.34e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGS2—malignant glioma	1.35e-05	2.33e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CA—malignant glioma	1.33e-05	2.29e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AKT1—malignant glioma	1.29e-05	2.22e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NCOR1—malignant glioma	1.29e-05	2.21e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.29e-05	2.21e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.28e-05	2.19e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.22e-05	2.1e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGS2—malignant glioma	1.21e-05	2.08e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CB—malignant glioma	1.19e-05	2.05e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AKT1—malignant glioma	1.18e-05	2.03e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTEN—malignant glioma	1.18e-05	2.03e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGS2—malignant glioma	1.18e-05	2.03e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.12e-05	1.93e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.11e-05	1.91e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGS2—malignant glioma	1.11e-05	1.91e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGS2—malignant glioma	1.1e-05	1.89e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AKT1—malignant glioma	1.09e-05	1.87e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTEN—malignant glioma	1.05e-05	1.81e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CAV1—malignant glioma	1.05e-05	1.81e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTEN—malignant glioma	1.03e-05	1.77e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTEN—malignant glioma	9.7e-06	1.67e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CA—malignant glioma	9.62e-06	1.65e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTEN—malignant glioma	9.62e-06	1.65e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CG—malignant glioma	9.58e-06	1.64e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PPARG—malignant glioma	9.24e-06	1.59e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CD—malignant glioma	8.42e-06	1.45e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CA—malignant glioma	8.33e-06	1.43e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AKT1—malignant glioma	7.86e-06	1.35e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CA—malignant glioma	7.44e-06	1.28e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CB—malignant glioma	7.34e-06	1.26e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS2—malignant glioma	7.27e-06	1.25e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CA—malignant glioma	7.26e-06	1.25e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CA—malignant glioma	6.84e-06	1.17e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AKT1—malignant glioma	6.81e-06	1.17e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CA—malignant glioma	6.78e-06	1.16e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTEN—malignant glioma	6.34e-06	1.09e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AKT1—malignant glioma	6.08e-06	1.04e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AKT1—malignant glioma	5.93e-06	1.02e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AKT1—malignant glioma	5.59e-06	9.6e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AKT1—malignant glioma	5.54e-06	9.51e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.47e-06	7.68e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AKT1—malignant glioma	3.65e-06	6.27e-06	CbGpPWpGaD
